GCI Magazine

Marketers Sponsored by

Email This Item!
Increase Text Size

J&J Opens New Innovation Center in London

Posted: March 13, 2013

Johnson & Johnson announced the opening of the Johnson & Johnson Innovation Centre in London, one of four regional hubs being established this year in the world’s leading innovation hotspots. A part of Johnson & Johnson innovation, the goal of the London Innovation Centre is to accelerate the best early stage science in the world and advance the development of new health care solutions for pharmaceutical and consumer products.

"Britain has a worldwide reputation for excellence in innovation—the investment by Johnson & Johnson here demonstrates this and I am delighted to welcome this new center to the U.K.," says U.K. Secretary of State for Health Jeremy Hunt, who will be speaking at the Innovation Expo 2013 on Wednesday.

Johnson & Johnson chief scientific officer and worldwide chairman, pharmaceuticals, Paul Stoffels, MD, says, “The London Innovation Centre is part of Johnson & Johnson’s broader innovation strategy to advance human health through collaboration with the world’s leading scientists and entrepreneurs. We are looking forward to collaborating within the UK, home to one of the world’s thriving life sciences ecosystems.”

The Johnson & Johnson family of companies has been investing in the United Kingdom since 1927 and supports directly or indirectly more than 24,000 jobs. The London Innovation Centre will be one of more than a dozen facilities of the Johnson & Johnson family of companies in the country.

In addition to the new Johnson & Johnson Innovation Centre in London, similar facilities are planned in Boston, San Francisco and later this year, Shanghai. Each city was selected for its robust life sciences community. And the Johnson & Johnson Innovation Centre in London will house science and technology experts with broad expertise in developing new solutions and products. The center will have local deal-making capabilities to flexibly adapt deal structures to match early-stage opportunities. This will enable scientists, entrepreneurs and emerging companies to deliver innovation via collaboration with experts who can drive partnerships across the pharmaceutical, medical device and diagnostics, and consumer health care companies of Johnson & Johnson.